06.10.26 -- A Peek Into Novo Nordisk's Sustainable Facility Construction Mindset

Skin delivery platforms expand therapies by boosting convenience, stability, and adherence. Integrated formulation, device, and manufacturing development is key to confidently scale.

Discover how flexible, patient‑centric clinical packaging supports complex Phase IIa dosing while protecting timelines, ensuring compliance, and avoiding costly primary packaging changes.

Drug formulations demand more than single‑point viscosity data. Explore how rheology reveals stability, flow, and structural behavior across suspensions, topicals, and injectables.

Experience the benefits of faster, more effective CAR-T cell production with this innovative three-day short-cycle process, designed to enhance patient treatment outcomes while reducing costs.

Filtration removes contaminants to ensure safety and is essential in various applications, from lab-scale tasks to GMP production. See how its simplicity and reliability make it indispensable.

Go beyond the ELISA by leveraging mass spectrometry. Identify specific high-risk proteins and ensure your purification process meets the highest standards of safety.

Gain insight into strategies for accommodating the ever-increasing upstream titers and volumes to prevent downstream purification from becoming a bottleneck.

Follow this ELISA testing that analyzes a protein capture device for carryover effects after consecutive cycling of two different cell culture harvests.